The model for the development of cost-effectiveness capabilities in Iran's pharmaceutical industry
This study, conducted in Iran's pharmaceutical industry, investigates the development of cost-effectiveness capabilities, a vital component of operational capabilities. It presents five essential hypotheses contributing to these capabilities. Capable human resources, especially in crisis manage...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
REA Press
2023-06-01
|
| Series: | Computational Algorithms and Numerical Dimensions |
| Subjects: | |
| Online Access: | https://www.journal-cand.com/article_188453_59f26be20cb72a25d152e1730fa95062.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832580040194260992 |
|---|---|
| author | Soheil Azizi Borojerdi Reza Rasinojehdehi Seyed Najafi |
| author_facet | Soheil Azizi Borojerdi Reza Rasinojehdehi Seyed Najafi |
| author_sort | Soheil Azizi Borojerdi |
| collection | DOAJ |
| description | This study, conducted in Iran's pharmaceutical industry, investigates the development of cost-effectiveness capabilities, a vital component of operational capabilities. It presents five essential hypotheses contributing to these capabilities. Capable human resources, especially in crisis management related to environmental obstacles like international sanctions, foster creativity and cost-effectiveness. Hardware and software infrastructure supports international collaborations, enhancing overall quality. Documentation, organizational knowledge, and capacity enhancement further contribute to cost-effectiveness capabilities. Effective operations management, standardized routines, and the emergence of new routines stimulate creativity and cost reduction. This research offers insights into the formation of cost-effectiveness capabilities and underscores the significance of internal resources, collaborations, and efficient management practices. While focused on Iran's pharmaceutical sector, the proposed model can serve as a valuable framework for studying influencing factors on cost-effectiveness capabilities in other industries and countries. |
| format | Article |
| id | doaj-art-dba759ccad774a6a8c000db7219d9b87 |
| institution | Kabale University |
| issn | 2980-7646 2980-9320 |
| language | English |
| publishDate | 2023-06-01 |
| publisher | REA Press |
| record_format | Article |
| series | Computational Algorithms and Numerical Dimensions |
| spelling | doaj-art-dba759ccad774a6a8c000db7219d9b872025-01-30T11:22:05ZengREA PressComputational Algorithms and Numerical Dimensions2980-76462980-93202023-06-0122476210.22105/cand.2024.437589.1087188453The model for the development of cost-effectiveness capabilities in Iran's pharmaceutical industrySoheil Azizi Borojerdi0Reza Rasinojehdehi1Seyed Najafi2Department of Industrial Engineering, Science and Research Branch, Islamic Azad University, Tehran, Iran.Department of Industrial Engineering, Science and Research Branch, Islamic Azad University, Tehran, Iran.Department of Industrial Engineering, Science and Research Branch, Islamic Azad University, Tehran, Iran.This study, conducted in Iran's pharmaceutical industry, investigates the development of cost-effectiveness capabilities, a vital component of operational capabilities. It presents five essential hypotheses contributing to these capabilities. Capable human resources, especially in crisis management related to environmental obstacles like international sanctions, foster creativity and cost-effectiveness. Hardware and software infrastructure supports international collaborations, enhancing overall quality. Documentation, organizational knowledge, and capacity enhancement further contribute to cost-effectiveness capabilities. Effective operations management, standardized routines, and the emergence of new routines stimulate creativity and cost reduction. This research offers insights into the formation of cost-effectiveness capabilities and underscores the significance of internal resources, collaborations, and efficient management practices. While focused on Iran's pharmaceutical sector, the proposed model can serve as a valuable framework for studying influencing factors on cost-effectiveness capabilities in other industries and countries.https://www.journal-cand.com/article_188453_59f26be20cb72a25d152e1730fa95062.pdfcompetitive advantagesoperations capabilitycompetenciesquality capabilitymultiple case studies |
| spellingShingle | Soheil Azizi Borojerdi Reza Rasinojehdehi Seyed Najafi The model for the development of cost-effectiveness capabilities in Iran's pharmaceutical industry Computational Algorithms and Numerical Dimensions competitive advantages operations capability competencies quality capability multiple case studies |
| title | The model for the development of cost-effectiveness capabilities in Iran's pharmaceutical industry |
| title_full | The model for the development of cost-effectiveness capabilities in Iran's pharmaceutical industry |
| title_fullStr | The model for the development of cost-effectiveness capabilities in Iran's pharmaceutical industry |
| title_full_unstemmed | The model for the development of cost-effectiveness capabilities in Iran's pharmaceutical industry |
| title_short | The model for the development of cost-effectiveness capabilities in Iran's pharmaceutical industry |
| title_sort | model for the development of cost effectiveness capabilities in iran s pharmaceutical industry |
| topic | competitive advantages operations capability competencies quality capability multiple case studies |
| url | https://www.journal-cand.com/article_188453_59f26be20cb72a25d152e1730fa95062.pdf |
| work_keys_str_mv | AT soheilaziziborojerdi themodelforthedevelopmentofcosteffectivenesscapabilitiesiniranspharmaceuticalindustry AT rezarasinojehdehi themodelforthedevelopmentofcosteffectivenesscapabilitiesiniranspharmaceuticalindustry AT seyednajafi themodelforthedevelopmentofcosteffectivenesscapabilitiesiniranspharmaceuticalindustry AT soheilaziziborojerdi modelforthedevelopmentofcosteffectivenesscapabilitiesiniranspharmaceuticalindustry AT rezarasinojehdehi modelforthedevelopmentofcosteffectivenesscapabilitiesiniranspharmaceuticalindustry AT seyednajafi modelforthedevelopmentofcosteffectivenesscapabilitiesiniranspharmaceuticalindustry |